Schizophrenia

Did you know that schizophrenia affects more than 1 percent of the world's population?

See NARSAD Grants at work on the latest schizophrenia research

Schizophrenia is a severe, chronic, and generally disabling brain and behavior disorder. It is most accurately described as a psychosis - a type of illness that causes severe mental disturbances that disrupt normal thoughts, speech, and behavior. Schizophrenia is believed to be caused by a combination of genetic and environmental factors.

Positive symptoms may include delusions, thought disorders, and hallucinations. People with schizophrenia may hear voices other people don't hear, or believe other people are reading their minds, controlling their thoughts, or plotting to harm them. Negative symptoms may include avolition (a lack of desire or motivation to accomplish goals), lack of desire to form social relationships, and blunted affect and emotion. Cognitive symptoms involve problems with attention and memory, especially in planning and organization to achieve a goal. Cognitive deficits are the most disabling for patients trying to lead a normal life.

learn more about schizophrenia

Visit the Schizophrenia Research Forum, fully sponsored by the Brain & Behavior Research Foundation—a virtual community of scientists collaborating in their quest for causes, improved treatments, and better understanding of schizophrenia.

Visit the Schizophrenia Research Forum for more information about research

 

Young Investigators
Young Investigators
February 07, 2011
In January NARSAD announced grant awards to 214 new Young Investigators. Totaling $12.6 million, these grants are part of the continued investment NARSAD makes...
Mediation May Change the Brain
Mediation May Change the Brain
February 04, 2011
NARSAD-Funded Researcher Pinpoints Gene Mutation Linked To Schizophrenia that Should Significantly Improve Treatment NARSAD Independent Investigator Jonathan...
Jonathan Javitch, M.D., Ph.D., of Columbia University
Jonathan Javitch, M.D., Ph.D.
February 01, 2011
From The Quarterly, Winter 2011 NARSAD Scientific Council member Jonathan Javitch, M.D., Ph.D., of Columbia University, is part of a team that recently...
Bryan L. Roth, M.D., Ph.D
Bryan L. Roth, M.D., Ph.D
February 01, 2011
Bryan L. Roth, M.D., Ph.D., NARSAD Scientific Council member, is a well known expert on psychopharmacology. In recent years, he has developed several...
Marcia, Sean and Paul Garatt - a family battling schizophrenia, depression and anxiety
The Garatt Family
February 01, 2011
From The Quarterly, Winter 2011 No one knows better than the Garatt family how far research in mental illness has come – and how far it still has to go. Thirty...

Pages

Subscribe to